Consistent with these findings, levels of BMI1 expression in the human CD34+ cell fraction have been reported to correlate well with the progression and prognosis of myelodysplastic syndrome and chronic and acute myeloid leukemia [4], [10], suggesting a role of BMI1 in leukemic stem cells. The gene discussed is BMI1; the disease is myelodysplastic syndrome.